Qualification of a select one‐stage activated partial thromboplastin time‐based clotting assay and two chromogenic assays for the post‐administration monitoring of nonacog beta pegol
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 15 (10), 1901-1912
- https://doi.org/10.1111/jth.13787
Abstract
No abstract availableKeywords
Funding Information
- Physicians World Europe GmbH
- Novo Nordisk
This publication has 16 references indexed in Scilit:
- Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trialJournal of Thrombosis and Haemostasis, 2016
- Measuring factor IX activity of nonacog beta pegol with commercially available one‐stage clotting and chromogenic assay kits: a two‐center studyJournal of Thrombosis and Haemostasis, 2016
- Recombinant long‐acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trialsHaemophilia, 2016
- Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4)Thrombosis Research, 2016
- Current laboratory practices in the diagnosis and management of haemophilia: a global assessmentHaemophilia, 2015
- Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trialBlood, 2014
- Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activityThrombosis and Haemostasis, 2014
- Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9‐GP), a glycoPEGylated recombinant factor IXJournal of Thrombosis and Haemostasis, 2012
- Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia BBlood, 2011
- Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptideBlood, 2011